Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • D-N-Acetylgalactosamine: Technical Guidelines for Glycoprote

    2026-05-28

    D-N-Acetylgalactosamine: Technical Guidelines for Glycoprotein Analysis

    What This Product Solves

    D-N-Acetylgalactosamine (N-((3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide) is an endogenous metabolite and a key constituent of brain heteropolysaccharides, particularly glycoproteins. In neurological research, accurate mapping of glycoprotein structures and glycosylation pathways is critical for understanding neuronal signaling and metabolism. This product addresses the need for a high-purity, water-soluble biochemical reagent that is specifically compatible with aqueous workflows used in brain tissue glycoprotein analysis. The reliable solubility and purity profile of D-N-Acetylgalactosamine enable consistent preparation and execution of biochemical assays targeting glycoprotein constituents.

    For a detailed overview of the product's technical parameters and recommended usage, refer to the D-N-Acetylgalactosamine product page from APExBIO.

    Protocol Parameters

    • Solubility in water: 22.1 mg/mL or higher | Suitable for aqueous-based glycoprotein and glycosylation assays | Ensures complete dissolution in standard buffers used in brain tissue workflows | Product dossier
    • Storage temperature: -20°C (solid state) | Required for maintaining compound stability and purity | Prevents degradation and preserves analytical integrity; working solutions should not be stored long-term | Product dossier
    • Solubility in DMSO: 22.75 mg/mL or higher | Allows application in DMSO-compatible biochemical protocols | Offers flexibility for non-aqueous, non-ethanol-based assays in research workflows | Product dossier
    • Ethanol solubility: Insoluble | Not suitable for protocols requiring ethanol-based dissolution | Avoid ethanol as a solvent to prevent incomplete dissolution and inconsistent assay performance | Product dossier
    • Purity: ≥98% (HPLC, NMR confirmed) | Ensures reproducibility and minimizes interference in analytical workflows | High purity is essential for quantitative and structural glycoprotein studies | Product dossier

    Workflow Setup and QC Checklist

    Establishing a robust workflow with D-N-Acetylgalactosamine requires strict adherence to handling and preparation protocols. Below is a stepwise checklist to ensure reproducibility:

    1. Reagent Preparation: Dissolve D-N-Acetylgalactosamine in water or DMSO only, using the recommended concentration parameters. Verify complete dissolution visually and, if necessary, with gentle agitation.
    2. Buffer Compatibility: Confirm that all assay buffers are aqueous or DMSO-based; exclude ethanol to avoid precipitation or incomplete solubilization.
    3. Storage: Store solid compound at -20°C. Prepare working solutions fresh prior to each use; do not store reconstituted solutions long-term. Discard unused solutions after each session.
    4. Sample Handling: Minimize freeze-thaw cycles for both solid and dissolved forms. Use aliquots for single-use experiments when possible.
    5. Quality Control: Monitor reagent integrity by periodic HPLC or NMR analysis if available, especially when working with sensitive detection endpoints.

    For further technical guidance, see this article on technical use for brain glycoprotein analysis, which emphasizes the need for strict workflow adherence to ensure reproducible results. Additionally, this resource highlights essential considerations for glycosylation pathway studies in neurological research using D-N-Acetylgalactosamine.

    Common Failure Modes and Fixes

    • Incomplete dissolution: If undissolved particles remain, verify solvent identity (must be water or DMSO) and increase mixing time or temperature slightly if protocol allows. Never substitute with ethanol.
    • Loss of activity due to improper storage: If compound performance declines, confirm adherence to -20°C storage for the solid. Discard any working solution held beyond a single use session.
    • Inconsistent assay results: Possible causes include solvent incompatibility, use of degraded material, or residual ethanol from buffer components. Rigorously check all reagents and repeat dissolution and assay setup using fresh material.
    • Contamination or purity deviations: Use only certified high-purity batches and periodically confirm product integrity via analytical QC methods available in your facility.

    Scope and Limitations

    D-N-Acetylgalactosamine is specifically designed for research workflows analyzing glycoprotein constituents in neurological applications, including brain heteropolysaccharides analysis and glycosylation pathway mapping. Its high water and DMSO solubility make it inappropriate for protocols relying on ethanol as a solvent. The compound should not be used in workflows requiring long-term storage of working solutions, as stability data only support the solid form at -20°C. Applications outside brain glycoprotein research are not directly supported by the current product dossier, and cross-domain usage should be approached cautiously, with validation as required.

    Conclusion

    D-N-Acetylgalactosamine offers a reliable, high-purity option for researchers conducting detailed studies of glycoprotein structure and function in brain tissues. By strictly adhering to product-specific workflow parameters—solvent selection, storage conditions, and QC practices—researchers can achieve reproducible and accurate results. For full technical specifications and ordering information, refer to the D-N-Acetylgalactosamine page at APExBIO.